Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Levodopa Induced Dyskinesia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT03331848
What this trial is testing

Study to Evaluate the Efficacy, Safety, and Tolerability of PXT002331 (Foliglurax) in Reducing Levodopa-Induced Dyskinesia and Wearing OFF in Subjects With Parkinson's Disease Experiencing Motor Complications of Levodopa Therapy (ATTUNED)

Who this might be right for
Parkinson Disease
Prexton Therapeutics
Not applicableStudy completedNCT02200887
What this trial is testing

Sleep Homeostasis in Parkinson's Disease

Who this might be right for
Parkinson Disease
Salvatore Galati 48
Testing effectiveness (Phase 2)UnknownNCT04147949
What this trial is testing

AV-101 (L-4-chlorokynurenine) in Parkinson's Disease Subjects With Levodopa-Induced Dyskinesia

Who this might be right for
Parkinson DiseaseDyskinesia, Medication-InducedL-Dopa Causing Adverse Effects in Therapeutic Use
VistaGen Therapeutics, Inc. 20
Large-scale testing (Phase 3)Ended earlyNCT05116813
What this trial is testing

Open-label Safety Study of Dipraglurant (ADX48621) in Patients With Parkinson's Disease Receiving Levodopa-based Therapy

Who this might be right for
Parkinson DiseaseDyskinesia, Drug-InducedDyskinesias
Addex Pharma S.A. 17
Testing effectiveness (Phase 2)Study completedNCT00957918
What this trial is testing

Study of NP002 in Subjects With Idiopathic Parkinson's Disease to Treat Dyskinesias Due to Levodopa Therapy

Who this might be right for
Parkinson's Disease
Neuraltus Pharmaceuticals, Inc. 65
Testing effectiveness (Phase 2)Study completedNCT05148884
What this trial is testing

Study to Assess the Safety, Tolerability and Preliminary Efficacy of NLX-112 Versus Placebo in L-dopa-induced Dyskinesia

Who this might be right for
Medication-Induced Dyskinesia
Neurolixis SAS 27
Large-scale testing (Phase 3)WithdrawnNCT03987750
What this trial is testing

Safinamide for Levodopa-induced Dyskinesia (PD-LID)

Who this might be right for
Dyskinesia, Drug-InducedParkinson Disease
Zambon SpA
Not applicableUnknownNCT05795088
What this trial is testing

Continuous Theta Burst Stimulation as Potential Biomarker of Levodopa-induced Dyskinesias in Parkinson's Disease

Who this might be right for
Parkinson Disease
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 60
Not applicableUnknownNCT02578849
What this trial is testing

Common Noradrenergic Mechanisms in Parkinson´s Disease and L-DOPA Induced Dyskinesia

Who this might be right for
Parkinson´s Disease
Aarhus University Hospital 45
Testing effectiveness (Phase 2)Study completedNCT01385592
What this trial is testing

Evaluation of the Efficacy and Safety of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias

Who this might be right for
DyskinesiasParkinson DiseaseMovement Disorders+1 more
Novartis Pharmaceuticals 78
Testing effectiveness (Phase 2)Study completedNCT01336088
What this trial is testing

ADX48621 for the Treatment of Levodopa Induced Dyskinesia in Patients With Parkinson's Disease

Who this might be right for
Parkinson's Disease
Addex Pharma S.A. 83
Not applicableStudy completedNCT00467597
What this trial is testing

Developing Objective Measures of Levodopa Induced Dyskinesia: (Study 1)

Who this might be right for
DyskinesiasMovement DisordersParkinson Disease
US Department of Veterans Affairs 36
Not applicableStudy completedNCT01429207
What this trial is testing

Capturing Parkinson's Disease Medication Side Effects During Daily Activities

Who this might be right for
Parkinson's DiseaseDyskinesia
Great Lakes NeuroTechnologies Inc. 15
Not applicableUnknownNCT04173832
What this trial is testing

Clinical Study on Treatment of L-DOPA-Induced Dyskinesia With Tianqi Pingchan Granule Combined With Amantadine

Who this might be right for
L-DOPA-Induced Dyskinesia
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 100
Testing effectiveness (Phase 2)Study completedNCT04435431
What this trial is testing

A Clinical Study of Mesdopetam in Patients With Parkinson's Disease Experiencing Levodopa Induced Dyskinesia

Who this might be right for
Parkinson Disease
Integrative Research Laboratories AB 155
Post-approval studies (Phase 4)Ended earlyNCT00477802
What this trial is testing

Botulinum Toxin Type A (Botox) in the Management of Levodopa-Induced Peak-Dose Dyskinesias in Parkinson's Disease

Who this might be right for
Parkinson Disease
University of Cincinnati 8
Testing effectiveness (Phase 2)Study completedNCT01538329
What this trial is testing

Amantadine and L-DOPA-induced Dyskinesia in Early Parkinson's Disease

Who this might be right for
Parkinson Disease
University Hospital, Toulouse 210
Early research (Phase 1)Study completedNCT01023282
What this trial is testing

Safety and Tolerability Study Evaluating ACR325 in Parkinson's Disease Patients

Who this might be right for
Parkinson's DiseaseTolerability
NeuroSearch A/S 22
Early research (Phase 1)UnknownNCT06021756
What this trial is testing

Phase I Open-label Study of Low-dose Ketamine Infusion Treatment in Levodopa-Induced Dyskinesia in Parkinson's Disease

Who this might be right for
Levodopa-Induced DyskinesiaParkinson's Disease
University of Arizona 9
Testing effectiveness (Phase 2)Study completedNCT02657681
What this trial is testing

Prevention of Levodopa-induced Dyskinesias by Transcranial Static Magnetic Field Stimulation (tSMS)

Who this might be right for
Dyskinesia, Medication-InducedParkinson's Disease
Fundación de investigación HM 50
Next Page